180 related articles for article (PubMed ID: 9324062)
1. Homocysteine and vascular dysfunction.
Lentz SR
Life Sci; 1997; 61(13):1205-15. PubMed ID: 9324062
[TBL] [Abstract][Full Text] [Related]
2. [Homocysteine, endothelial dysfunction and cardiovascular risk: pathomechanisms and therapeutic options].
Sydow K; Böger RH
Z Kardiol; 2001 Jan; 90(1):1-11. PubMed ID: 11220081
[TBL] [Abstract][Full Text] [Related]
3. Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction.
Stühlinger MC; Stanger O
Curr Drug Metab; 2005 Feb; 6(1):3-14. PubMed ID: 15720202
[TBL] [Abstract][Full Text] [Related]
4. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia.
Böger RH; Bode-Böger SM; Sydow K; Heistad DD; Lentz SR
Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1557-64. PubMed ID: 10845872
[TBL] [Abstract][Full Text] [Related]
5. Vascular dysfunction in hyperhomocyst(e)inemia. Implications for atherothrombotic disease.
Stanger O; Weger M; Renner W; Konetschny R
Clin Chem Lab Med; 2001 Aug; 39(8):725-33. PubMed ID: 11592442
[TBL] [Abstract][Full Text] [Related]
6. Consequences of hyperhomocyst(e)inemia on vascular function in atherosclerotic monkeys.
Lentz SR; Malinow MR; Piegors DJ; Bhopatkar-Teredesai M; Faraci FM; Heistad DD
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2930-4. PubMed ID: 9409278
[TBL] [Abstract][Full Text] [Related]
7. Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease.
Manns BJ; Burgess ED; Hyndman ME; Parsons HG; Schaefer JP; Scott-Douglas NW
Am J Kidney Dis; 1999 Oct; 34(4):669-77. PubMed ID: 10516348
[TBL] [Abstract][Full Text] [Related]
8. Hyperhomocyst(e)inemia, anti-estrogen antibodies and other risk factors for thrombosis in women on oral contraceptives.
Beaumont V; Malinow MR; Sexton G; Wilson D; Lemort N; Upson B; Beaumont JL
Atherosclerosis; 1992 Jun; 94(2-3):147-52. PubMed ID: 1632868
[TBL] [Abstract][Full Text] [Related]
9. Homocyst(e)ine, oxidative stress, and endothelium function in uremic patients.
Massy ZA; Ceballos I; Chadefaux-Vekemens B; Nguyen-Khoa T; Descamps-Latscha B; Drüeke TB; Jungers P
Kidney Int Suppl; 2001 Feb; 78():S243-5. PubMed ID: 11169019
[TBL] [Abstract][Full Text] [Related]
10. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM.
Hofmann MA; Kohl B; Zumbach MS; Borcea V; Bierhaus A; Henkels M; Amiral J; Schmidt AM; Fiehn W; Ziegler R; Wahl P; Nawroth PP
Diabetes Care; 1998 May; 21(5):841-8. PubMed ID: 9589252
[TBL] [Abstract][Full Text] [Related]
11. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM.
Hofmann MA; Kohl B; Zumbach MS; Borcea V; Bierhaus A; Henkels M; Amiral J; Fiehn W; Ziegler R; Wahl P; Nawroth PP
Diabetes Care; 1997 Dec; 20(12):1880-6. PubMed ID: 9405911
[TBL] [Abstract][Full Text] [Related]
12. Hyperhomocyst(e)inemia in renal transplant recipients with and without cyclosporine.
Ducloux D; Fournier V; Rebibou JM; Bresson-Vautrin C; Gibey R; Chalopin JM
Clin Nephrol; 1998 Apr; 49(4):232-5. PubMed ID: 9582553
[TBL] [Abstract][Full Text] [Related]
13. Relation of plasma homocyst(e)ine to cerebral infarction and cerebral atherosclerosis.
Yoo JH; Chung CS; Kang SS
Stroke; 1998 Dec; 29(12):2478-83. PubMed ID: 9836754
[TBL] [Abstract][Full Text] [Related]
14. Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke.
Coull BM; Malinow MR; Beamer N; Sexton G; Nordt F; de Garmo P
Stroke; 1990 Apr; 21(4):572-6. PubMed ID: 2326839
[TBL] [Abstract][Full Text] [Related]
15. Homocyst(e)ine and coronary artery disease. Clinical evidence and genetic and metabolic background.
Moghadasian MH; McManus BM; Frohlich JJ
Arch Intern Med; 1997 Nov; 157(20):2299-308. PubMed ID: 9361570
[TBL] [Abstract][Full Text] [Related]
16. Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia.
Lentz SR; Sobey CG; Piegors DJ; Bhopatkar MY; Faraci FM; Malinow MR; Heistad DD
J Clin Invest; 1996 Jul; 98(1):24-9. PubMed ID: 8690798
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular morbidity and endothelial dysfunction in chronic haemodialysis patients: is homocyst(e)ine the missing link?
Kunz K; Petitjean P; Lisri M; Chantrel F; Koehl C; Wiesel ML; Cazenave JP; Moulin B; Hannedouche TP
Nephrol Dial Transplant; 1999 Aug; 14(8):1934-42. PubMed ID: 10462274
[TBL] [Abstract][Full Text] [Related]
18. Association between homocyst(e)ine levels and risk of vascular events.
Kaplan ED
Drugs Today (Barc); 2003 Mar; 39(3):175-92. PubMed ID: 12730702
[TBL] [Abstract][Full Text] [Related]
19. Patients with atherosclerotic vascular disease: how low should plasma homocyst(e)ine levels go?
Spence JD
Am J Cardiovasc Drugs; 2001; 1(2):85-9. PubMed ID: 14728038
[TBL] [Abstract][Full Text] [Related]
20. Genetic and nongenetic factors for moderate hyperhomocyst(e)inemia.
Kang SS; Wong PW
Atherosclerosis; 1996 Jan; 119(2):135-8. PubMed ID: 8808490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
